Buy ImmunoCellular Therapeutics Stock | IMUC Stock Price & Latest News | Public.com
IMUC

ImmunoCellular Therapeutics

$0.00 (0.00%)Today
    Small Market Cap
    View ImmunoCellular Therapeutics (IMUC) stock trends here

    About IMUC

    ImmunoCellular Therapeutics, Ltd. is a clinical-stage company, which engages in the development of immune-based therapies for the treatment of cancers. The company's lead product candidate, ICT-107, is a dendritic cell-based immunotherapy targeting multiple tumor-associ...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    Stats

    Market Cap$2,05M
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$0.98
    1 Year Low$0.06
    Open
    High
    Low

    Buy any stock with any amount of money.

    Download the App
    Download the app